The Secretary General
SUBSCRIBE to OACPS PULSE
Intra-ACP Programmes

INTRA-ACP PROGRAMMING MATRIX
ACP in Action: Interactive Map of Intra-ACP Projects in the Member States
Action Against Desertification
African Peace Facility
Aviation Africa
Biodiversity and Protected Areas Management (BIOPAMA)
ACP Business Climate
COLEACP
Competitive Industries and Innovation Programme
Coton ACP
ACP EU Culture / ACP UE Culture
ACP-EU Commodities Programme
ACP-EU Development Minerals Programme
ACP-EU Energy Facility
ACP-EU EDULINK Programme
ACP-EU Fish II Programme
Global Climate Change Alliance (GCCA Intra-ACP)
Hub & Spokes - Enhancing Trade Capacity in ACP
Initiative Francophone Por La Formation A Distance Des Maitres (IFADEM)
Intra-ACP Agricultural Policy Programme (APP)
Intra-ACP Academic Mobility Scheme
ACP Multilateral Environmental Agreements
ACP-EU Microfinance Programme
ACP-EU Migration Action
Minising the Illegal Killing of Elephants (MIKES)
ACP Mining Database
ACP MEAs (Multilateral Environmental Agreements)
ACP Multilateral Trading System Programme
ACP-EU Natural Disaster Risk Reduction Programme
ACP Observatory on Migration
Participatory Slum Upgrading Programme
Renewed Partnership: Strengthening pharmaceutical systems and improving access to quality medicines
ACP-EU Science and Technology
Strengthening Fishery Products
ACP-EU Technical Barriers to Trade Programme
ACP-EU Water Facility
Centre Technique de Coopération Agricole et Rurale (CTA)
TRADECOM
Sustainable Wildlife Management (SWM) Programme  / Programme de gestion durable de la faune sauvage (SWM) 

Home

OACPS Secretary-General endorses EU Candidate, Dr Chrysoula Zacharopoulou for post of Co-Chair of the COVAX Facility Shareholders Council

Printer-friendly versionPDF version

Brussels, 15 March 2021/OACPS: The Secretary-General of the Organisation of African, Caribbean and Pacific States (OACPS), H.E. Mr Georges Rebelo Pinto Chikoti, has endorsed the candidate proposed by the European Union (EU), MEP Dr Chrysoula Zacharopoulou, MD, PhD of France, for the post of Co-Chair of the COVAX Facility Shareholders Council, following a recent meeting of the Bureau of the Committee of Ambassadors.

“The OACPS has had a long and enduring partnership with the EU, which has been a strong supporter of the COVAX facility and ACT-A. Team Europe is also one of the lead contributors to COVAX with an investment of over € 2.2 billion and has already started to make good on its stated intention of ensuring equitable global access to vaccines. Having spoken with Dr Zacharopoulou, I believe she represents the values we expect and is an ideal candidate for this post at this time.” Secretary Chikoti further added that Dr Zacharopoulou would also provide gender-balanced leadership for the Facility.

Dr Zacharopoulou, currently EU Vice-President of the ACP-EU Joint Parliamentary Assembly (JPA), is also vice-chair of the Committee on Development and the Parliament’s rapporteur on the Africa-EU strategy, as well as a Member of the Environment, Public Health and Food Safety Committee and the Committee on Women’s Rights and Gender Equality in the European Parliament. Familiar both with the issues of concern to the OACPS and more specifically, COVID-19 and the rollout of the vaccines, she has worked actively in the OACPS, assisting most recently in a mission to Rwanda to assist in the COVID-19 vaccination campaign.

The EU considers Dr Zacharopoulou, a surgeon-gynecologist who also holds an executive Master’s degree in Public Health, to be eminently suited to serve in the post, as she brings a multi-faceted experience as a physician and a politician and a fresh view on global Health. Dr Zacharopoulou’s career experience has also prepared her to understand and be responsive to the mission of the COVAX Facility as well as the needs, concerns and contributions of COVAX stakeholders, the private sector, civil society and public-private partnership at all levels.

Currently, thirteen Members of the OACPS are among the list of 92 countries to be assisted by COVAX and 14 Members are on the COVAX Facility Shareholders Council.

COVAX is one of the three pillars of the Access to COVID-19 Tools (ACT) Accelerator, a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi – the Vaccine Alliance and the World Health Organization (WHO), alongside key delivery partner, the United Nations International Children’s Emergency Fund (UNICEF). Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world.

 


Rue de l'Aqueduc 118
Ixelles - 1050, Bruxelles - Brussels
Belgique - Belgium
email : info@acp.int
Tel: +32 2 743 06 00
Fax: +32 2 735 55 73
see map/voir plan

Languages

    

Events
« June 2022 »
MonTueWedThuFriSatSun
12345
6789101112
13141516171819
20212223242526
27282930
ACP Public Documents
User login


The ACP Group is a registered trademark. The ACP logo and material on this site are protected by copyright laws and international treaty provisions. Unauthorised use of the ACP logo or copyright material without written permission is punishable by law.